XENE
Xenon Pharmaceuticals IncstockNASDAQ
At CloseNov 3, 2026 3:59:58 PM EST
38.23USD+1.621%(+0.61)1,246,675
Pre-marketNov 3, 2026 9:28:30 AM EST
37.75USD+0.346%(+0.13)
XENE News
Xenon to Present at Upcoming Investor Conferences ·
GlobeNewswire Inc.
Xenon to Report Q3 2026 Financial Results on November 9, 2026 ·
GlobeNewswire Inc.
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ·
GlobeNewswire Inc.+1 source
Xenon Pharmaceuticals advances pain drugs to phase 2 trials ·
Investing.com
Xenon Pharmaceuticals stock hits 52-week low at 35.04 USD ·
Investing.com
Xenon Pharmaceuticals stock hits 52-week low at 36.06 USD ·
Investing.com
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ·
GlobeNewswire Inc.+1 source
Why is Xenon Pharmaceuticals stock rallying today? ·
Investing.com
Thursday 10/1 Insider Buying Report: XENE ·
BNK Invest
Xenon to Present at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit ·
GlobeNewswire Inc.+1 source
